A feature conferring uniqueness to the Alb-R26Met “inside-out” cancer model is its ability to recapitulate, in an immune competent context, the temporal heterogeneity of tumor onset and the molecular heterogeneity of human HCC patients.24 Here, ALB is linked to hepatocellular carcinoma.